Literature DB >> 27768111

Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.

Xiao-Feng Xiong1, Hang Zhang1, Christina R Underwood1, Kasper Harpsøe1, Thomas J Gardella2, Mie F Wöldike1, Michael Mannstadt2, David E Gloriam1, Hans Bräuner-Osborne1, Kristian Strømgaard1.   

Abstract

G proteins are key mediators of G protein-coupled receptor signalling, which facilitates a plethora of important physiological processes. The cyclic depsipeptides YM-254890 and FR900359 are the only known specific inhibitors of the Gq subfamily of G proteins; however, no synthetic route has been reported previously for these complex natural products and they are not easily isolated from natural sources. Here we report the first total synthesis of YM-254890 and FR900359, as well as of two known analogues, YM-385780 and YM-385781. The versatility of the synthetic approach also enabled the design and synthesis of ten analogues, which provided the first structure-activity relationship study for this class of compounds. Pharmacological characterization of all the compounds at Gq-, Gi- and Gs-mediated signalling provided succinct information on the structural requirements for inhibition, and demonstrated that both YM-254890 and FR900359 are highly potent inhibitors of Gq signalling, with FR900359 being the most potent. These natural products and their analogues represent unique tools for explorative studies of G protein inhibition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27768111      PMCID: PMC5559716          DOI: 10.1038/nchem.2577

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  36 in total

1.  A holistic view of GPCR signaling.

Authors:  Terry Kenakin
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

2.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

Authors:  D M Gill; R Meren
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 3.  Amino acid-protecting groups.

Authors:  Albert Isidro-Llobet; Mercedes Alvarez; Fernando Albericio
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

Review 4.  Contemporary strategies for peptide macrocyclization.

Authors:  Christopher J White; Andrei K Yudin
Journal:  Nat Chem       Date:  2011-06-23       Impact factor: 24.427

5.  Total synthesis of the cyclic depsipeptide YM-280193, a platelet aggregation inhibitor.

Authors:  Harveen Kaur; Paul W R Harris; Peter J Little; Margaret A Brimble
Journal:  Org Lett       Date:  2015-01-15       Impact factor: 6.005

Review 6.  Mammalian G proteins and their cell type specific functions.

Authors:  Nina Wettschureck; Stefan Offermanns
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

7.  A viable synthesis of N-methyl cysteine.

Authors:  Erik L Ruggles; Stevenson Flemer; Robert J Hondal
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

8.  Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.

Authors:  R E West; J Moss; M Vaughan; T Liu; T Y Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

9.  YM-254890 analogues, novel cyclic depsipeptides with Galpha(q/11) inhibitory activity from Chromobacterium sp. QS3666.

Authors:  Masatoshi Taniguchi; Ken-Ichi Suzumura; Koji Nagai; Tomihisa Kawasaki; Jun Takasaki; Mitsuhiro Sekiguchi; Yumiko Moritani; Tetsu Saito; Kazumi Hayashi; Shigeo Fujita; Shin-Ichi Tsukamoto; Ken-Ichi Suzuki
Journal:  Bioorg Med Chem       Date:  2004-06-15       Impact factor: 3.641

10.  Total synthesis of pactamycin and pactamycate: a detailed account.

Authors:  Stephen Hanessian; Ramkrishna Reddy Vakiti; Stéphane Dorich; Shyamapada Banerjee; Benoît Deschênes-Simard
Journal:  J Org Chem       Date:  2012-10-19       Impact factor: 4.354

View more
  17 in total

1.  The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway.

Authors:  Stine Engesgaard Jacobsen; Ina Ammendrup-Johnsen; Anna Mai Jansen; Ulrik Gether; Kenneth Lindegaard Madsen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

2.  Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma.

Authors:  Dominic Lapadula; Eduardo Farias; Clinita E Randolph; Timothy J Purwin; Dougan McGrath; Thomas H Charpentier; Lihong Zhang; Shihua Wu; Mizue Terai; Takami Sato; Gregory G Tall; Naiming Zhou; Philip B Wedegaertner; Andrew E Aplin; Julio Aguirre-Ghiso; Jeffrey L Benovic
Journal:  Mol Cancer Res       Date:  2018-12-19       Impact factor: 5.852

Review 3.  Targeting G protein-coupled receptor signalling by blocking G proteins.

Authors:  Adrian P Campbell; Alan V Smrcka
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

4.  Delineation of molecular determinants for FR900359 inhibition of Gq/11 unlocks inhibition of Gαs.

Authors:  Michael W Boesgaard; Kasper Harpsøe; Michelle Malmberg; Christina R Underwood; Asuka Inoue; Jesper M Mathiesen; Gabriele M König; Evi Kostenis; David E Gloriam; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

Review 5.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

6.  Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways.

Authors:  Ming-Wei Wang; Zhao Yang; Xu Chen; Shu-Hua Zhou; Ge-Lin Huang; Jian-Ning Sun; Hui Jiang; Wen-Ming Xu; Hao-Cheng Lin; Xiao Yu; Jin-Peng Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 11.205

7.  Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?

Authors:  Jonathan G Schlegel; Mariam Tahoun; Alexander Seidinger; Jan H Voss; Markus Kuschak; Stefan Kehraus; Marion Schneider; Michaela Matthey; Bernd K Fleischmann; Gabriele M König; Daniela Wenzel; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-19

8.  Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.

Authors:  Gabriella Bayshtok; Emilie Ceraudo; Tyler D Hitchman; Amanda R Moore; Cindy Lee; Ruobing Jia; Naitao Wang; Mohini R Pachai; Alexander N Shoushtari; Jasmine H Francis; Youxin Guan; Juliet Chen; Matthew T Chang; Barry S Taylor; Thomas P Sakmar; Thomas Huber; Ping Chi; Yu Chen
Journal:  Clin Cancer Res       Date:  2020-11-23       Impact factor: 13.801

9.  Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity.

Authors:  Davide Malfacini; Julian Patt; Suvi Annala; Kasper Harpsøe; Funda Eryilmaz; Raphael Reher; Max Crüsemann; Wiebke Hanke; Hang Zhang; Daniel Tietze; David E Gloriam; Hans Bräuner-Osborne; Kristian Strømgaard; Gabriele M König; Asuka Inoue; Jesus Gomeza; Evi Kostenis
Journal:  J Biol Chem       Date:  2019-02-11       Impact factor: 5.157

10.  Knockin mouse with mutant Gα11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors.

Authors:  Kelly L Roszko; Ruiye Bi; Caroline M Gorvin; Hans Bräuner-Osborne; Xiao-Feng Xiong; Asuka Inoue; Rajesh V Thakker; Kristian Strømgaard; Thomas Gardella; Michael Mannstadt
Journal:  JCI Insight       Date:  2017-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.